PLAYBACK SESSIONS
MARCH 31
2021
DECEMBER 10
2020
Tumor Mutational Burden (TMB): Foundation Medicine’s approach of assay development and clinical utility.
DECEMBER 3
2020
Loss of heterozygosity (LOH) scoring and cutoff value as part of an algorithm to determine the homologous recombination deficiency (HRD) status.
Previous Webinars
JULY 15
Genomic alterations as guides for resistance/response to immunotherapy: Looking beyond TMB, MSI, PD-L1
Webinar Presentation
Genomic Alterations as Guides for Resistance/Response to Immunotherapy: Looking Beyond TMB, MSI, PD-L1
Webinar recording
MARCH 31
Exploring fusion genes in cancer with comprehensive genomic profiling
Webinar Presentation
Gene Fusions in Comprehensive Genomic Profiling
Webinar recording
December 10
Tumor Mutational Burden (TMB)
Tumor Mutational Burden (TMB): Foundation Medicine’s approach of assay development and clinical utility.
TMB Webinar Presentation
Tumor Mutational Burden as a Biomarker for Immunotherapy
Webinar recording
December 3
LOSS OF HETEROZYGOSITY IN OVARIAN CANCER
Loss of heterozygosity (LOH) scoring and cutoff value as part of an algorithm to determine the homologous recombination deficiency (HRD) status.
HRD and LOH Webinar Presentation
Homologous Recombination Repair (HRR), Clinical Validation of HRRm, HRD v HRRm, Clinical applications of HRD biomarkers